Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8309718 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors

Patent 8309718 was granted and assigned to Incyte on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83097180

Patent Inventor Names

James D. Rodgers0

Wenqing Yao0

Yun-Long Li0

Date of Patent

November 13, 2012

Patent Application Number

122701350

Date Filed

November 13, 2008

Patent Citations Received

‌

US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

‌

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

‌

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

‌

US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders

‌

US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors

‌

US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

‌

US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo

Patent Primary Examiner

‌

James O. Wilson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8309718 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API